Prescription drug · ANDA
Lincomycin NDC 42571-374
Lincomycin hydrochloride 300 mg/mL · Injection, Solution · Intramuscular, Intravenous · Micro Labs Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 42571-374-75 | 42571037475 | 1 VIAL in 1 CARTON (42571-374-75) / 2 mL in 1 VIALMarketed from Feb 1, 2022 | |
| 42571-374-88 | 42571037488 | 1 VIAL in 1 CARTON (42571-374-88) / 10 mL in 1 VIALMarketed from Feb 1, 2022 | |
| 42571-374-89 | 42571037489 | 10 VIAL in 1 CARTON (42571-374-89) / 10 mL in 1 VIALMarketed from Aug 1, 2026 | |
| 42571-374-91 | 42571037491 | 10 VIAL in 1 CARTON (42571-374-91) / 2 mL in 1 VIALMarketed from Aug 1, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lincomycin
- Generic name (nonproprietary)
- lincomycin
- Active ingredients
- Lincomycin hydrochloride — 300 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intramuscular, Intravenous
- Labeler
- Micro Labs Limited
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 215082
- Marketing start
- Listing expires
- Identifiers
- Product ID 42571-374_5834c892-22e9-1e32-e063-6294a90a0ae5SPL ID 5834c892-22e9-1e32-e063-6294a90a0ae5SPL set ID 20c0e8af-a78f-47f8-ace4-06b80def7003RxCUI 239212UNII M6T05Z2B68UPC 0342571374891, 0342571374914
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N442571037475followed by a unit qualifier and the quantityPackage 42571-0374-75. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Lincomycin injection is indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of CDAD, as described in the BOXED WARNING , before selecting lincomycin the physician should consider the nature of the infection and the suitability of other alternatives. Indicated surgical procedures should be performed in conjunction with antibacterial therapy. Lincomycin injection may be administered concomitantly with other antimicrobial agents wh…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 215082
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lincomycin | Lincomycin hydrochloride 3000 mg/10mL | Injection, SolutionIntramuscular, Intravenous | Armas Pharmaceuticals Inc. | 72485-115 |
| Lincomycin | Lincomycin hydrochloride 600 mg/2mL | Injection, SolutionIntramuscular, Intravenous | Armas Pharmaceuticals Inc. | 72485-114 |